Drug interactions with radiopharmaceuticals
- 1 April 1994
- journal article
- review article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 21 (4), 348-356
- https://doi.org/10.1007/bf00947972
Abstract
Considerable information on documented drug and radiopharmaceutical interactions has been assembled in a tabular form, classified by the type of nuclear medicine study. The aim is to provide a rapid reference for nuclear medicine staff to look for such interactions. The initiation of drug chart monitoring or drug history taking of nuclear medicine patients and the reporting of such events are encouraged.Keywords
This publication has 66 references indexed in Scilit:
- Diffuse Liver Uptake of Tc-99m Phosphate Compound Associated with Intravenous Injection of Iron Colloid SolutionClinical Nuclear Medicine, 1993
- Adverse Reactions and Drug Interactions with RadiopharmaceuticalsDrug Safety, 1993
- State-of-the-art review: Captopril renography—Pathophysiological considerations and clinical observationsSeminars in Nuclear Medicine, 1992
- The effect of atenolol on dipyridamole 201T1 myocardial perfusion tomography in patients with coronary artery diseaseNuclear Medicine Communications, 1992
- The effect of beta blockade on single photon emission computed tomographic (SPECT) thallium-201 images in patients with coronary diseaseAmerican Heart Journal, 1989
- Erythromycin HepatotoxicityClinical Nuclear Medicine, 1986
- Drug-induced changes in the biologic distribution of radiopharmaceuticalsSeminars in Nuclear Medicine, 1982
- Iatrogenic alterations in radionuclide biodistributionsSeminars in Nuclear Medicine, 1979
- Methotrexate-lnduced Ventriculitis: Appearance on Routine Radionuclide Scan and Emission Computed TomographyClinical Nuclear Medicine, 1978
- Hyperprolactinaemia as a cause of gallium-67 uptake in the breastThe British Journal of Radiology, 1976